SCHEMBL21921025

SCHEMBL21921025

CCOC(C)c1cccc(Cl)c1Cl

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PNMT P11086 2/20 0.53
▸ CYP1A2 P05177 1/20 0.53
▸ CYP3A4 P08684 1/20 0.53
▸ CYP2D6 P10635 1/20 0.53
▸ NFKB1 P19838 1/20 0.53
▸ ALDH1A1 P00352 2/20 0.52
▸ LMNA P02545 2/20 0.52
▸ GLA P06280 1/20 0.52
▸ IDO1 P14902 3/20 0.40
▸ TDO2 P48775 1/20 0.40
▸ MEN1 O00255 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ CASP1 P29466 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ TAS1R3 Q7RTX0 1/20 0.35
▸ TAS1R1 Q7RTX1 1/20 0.35
▸ TAS1R2 Q8TE23 1/20 0.35
▸ ADRB2 P07550 1/20 0.34
▸ ADRB1 P08588 1/20 0.34
▸ KCNH2 Q12809 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22824154 0.85 CASP1 (0.44) PNMTCYP1A2CYP3A4CYP2D6NFKB1
SCHEMBL2632877 0.75 PNMT (0.59) PNMTCYP1A2CYP3A4CYP2D6NFKB1
SCHEMBL423182 0.73 CYP1A2 (0.68) PNMTCYP1A2CYP3A4CYP2D6NFKB1
SCHEMBL22801396 0.73 CYP1A2 (0.68) PNMTCYP1A2CYP3A4CYP2D6NFKB1
SCHEMBL8460681 0.73 CYP1A2 (0.52) PNMTCYP1A2CYP3A4CYP2D6NFKB1
SCHEMBL9770072 0.72 PNMT (0.55) PNMTCYP1A2CYP3A4CYP2D6NFKB1
SCHEMBL2632878 0.72 PNMT (0.55) PNMTCYP1A2CYP3A4CYP2D6NFKB1
SCHEMBL21776127 0.72 PNMT (0.55) PNMTCYP1A2CYP3A4CYP2D6NFKB1
SCHEMBL8750426 0.72 ADRA2A (0.40) CYP1A2CYP3A4CYP2D6NFKB1ALDH1A1
SCHEMBL11501928 0.71 CYP1A2 (0.65) PNMTCYP1A2CYP3A4CYP2D6NFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020063760-A1 NOVEL HETEROCYCLIC DERIVATIVES USEFUL AS SHP2 INHIBITORS JACOBIO PHARMACEUTICALS CO., LTD. (CN) 2020-04-02 — — WO disclosed
Send feedback